| Benign Prostatic Hyperplasia |
1 |
1 |
| Prostate |
0 |
0.92 |
| Prostatic Enlargement |
0 |
0.78 |
| Transurethral Resection of the Prostate |
0 |
0.6 |
| Prostate Cancer |
0 |
0.58 |
| Prostate Specific Antigen |
0 |
0.57 |
| Elevated Prostate Specific Antigen |
0 |
0.52 |
| Laser |
0 |
0.18 |
| Pain Management |
0 |
0.18 |
| Urethra |
0 |
0.18 |
| Urethral Stricture |
0 |
0.17 |
| Acute Pain |
0 |
0.15 |
| Stress Incontinence |
0 |
0.14 |
| Gland |
0 |
0.12 |
| Hematuria |
0 |
0.12 |
| Incontinence |
0 |
0.12 |
| Tissue |
0 |
0.12 |
| Urinary Tract Infection |
0 |
0.1 |
| Erectile Dysfunction |
0 |
0.09 |
| General Anesthesia |
0 |
0.09 |
| Urinary Incontinence |
0 |
0.08 |
| Anesthesia |
0 |
0.06 |
| Antigens |
0 |
0.06 |
| Bladder |
0 |
0.06 |
| Canada |
0 |
0.06 |
| Catheterization |
0 |
0.06 |
| Chemotherapy |
0 |
0.06 |
| Dysuria |
0 |
0.06 |
| Ejaculation Disorder |
0 |
0.06 |
| Fertility |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| New York |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Pharmacokinetics |
0 |
0.06 |
| Postoperative |
0 |
0.06 |
| Resection |
0 |
0.06 |
| Sedative |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Urinary Urgency |
0 |
0.06 |